Abstract |
KR-31543, (2S,3R,4S)-6-amino-4-[N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amino]-3,4-dihydro-2-dimethoxymethyl-3-hydroxy-2-methyl-2H-1- benzopyran is a new neuroprotective agent for ischemia- reperfusion damage. The in vitro and in vivo metabolism of KR-31543 in rats has been studied by LC-electrospray mass spectrometry. Rat liver microsomal incubation of KR-31543 in the presence of NADPH resulted in the formation of a metabolite M1. M1 was identified as N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amine on the basis of LC-MS/MS analysis with the synthesized authentic standard. Rat CYP3A1 and 3A2 are the major CYP isozymes involved in the formation of M1.
|
Authors | John Kim, Hye Young Ji, Seung-Seok Lee, Sung-Eun Yoo, Sun Ok Kim, Dong Ha Lee, Hong Lim, Hye Suk Lee |
Journal | Archives of pharmacal research
(Arch Pharm Res)
Vol. 25
Issue 5
Pg. 664-8
(Oct 2002)
ISSN: 0253-6269 [Print] Korea (South) |
PMID | 12433202
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzopyrans
- KR-31543
- Neuroprotective Agents
- Tetrazoles
- Aryl Hydrocarbon Hydroxylases
- Cyp3a23-3a1 protein, rat
- Cytochrome P-450 CYP3A
|
Topics |
- Animals
- Aryl Hydrocarbon Hydroxylases
- Benzopyrans
(chemistry, metabolism, therapeutic use)
- Chromatography, Liquid
(methods)
- Cytochrome P-450 CYP3A
- Male
- Microsomes, Liver
(drug effects, metabolism)
- Neuroprotective Agents
(chemistry, metabolism, therapeutic use)
- Rats
- Rats, Sprague-Dawley
- Reperfusion Injury
(drug therapy, metabolism)
- Spectrometry, Mass, Electrospray Ionization
(methods)
- Tetrazoles
(chemistry, metabolism, therapeutic use)
|